Immunogenicity for Biotherapeutics

Date: 10-Nov-15 to 11-Nov-15
Location: Hyatt Regency Reston / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

As the longest and most comprehensive event on predicting and de-risking immune responses from concept to product, the 16th annual Immunogenicity for Biotherapeutics event delivers key insights and case studies to remove the uncertainty surrounding immune response prediction and minimization. With strategies to overcome immunogenicity challenges from pre-clinical and development all the way through post-clinical stages, this event is a "can't miss" to create reliable, predictable, and worthwhile tests to improve biologic safety.

Key Benefits Include:

Exclusive access to senior FDA and industry experts, offering unmatched state-of-the-art insight from both technical and regulatory perspectives.
Strategies and case studies to help understand, anticipate, and mitigate the risks of immunogenicity from concept to product
Create and capitalize on the most advanced transgenic animal models to get the best grasp on predicting immunogenicity
Identify the must-have features of molecular design to minimize or eliminate epitopes
Adapt your skills to the unique features of newly-developed varieties of biomolecules, including biosimilars, nanomedicines, bispecifics and antibody-drug conjugates
Insights from industry thought leaders on managing and reducing off-target toxicity concerns with antibody-drug conjugates and other protein therapeutics
Updates on higher-order structure techniques and assessment to improve the safety of therapeutic candidates

Go to event website